Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
15464 | 711 | 25.1 | 59% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
156 | 3 | MYCOSES//MYCOLOGY//CANDIDA ALBICANS | 62026 |
1247 | 2 | ONYCHOMYCOSIS//DERMATOPHYTES//DERMATOPHYTOSIS | 8986 |
15464 | 1 | KETOCONAZOLE//NONLINEAR LIVER BINDING//840 SHERBROOK ST | 711 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | KETOCONAZOLE | authKW | 156493 | 8% | 6% | 57 |
2 | NONLINEAR LIVER BINDING | authKW | 85891 | 0% | 100% | 2 |
3 | 840 SHERBROOK ST | address | 42946 | 0% | 100% | 1 |
4 | ATHEROGENIC RISK INDEX | authKW | 42946 | 0% | 100% | 1 |
5 | AZOL ANTIFUNGALS | authKW | 42946 | 0% | 100% | 1 |
6 | AZOLE CYTOCHROME P450 INTERACTIONS | authKW | 42946 | 0% | 100% | 1 |
7 | AZOLE PROBES | authKW | 42946 | 0% | 100% | 1 |
8 | BIS4 FLUOROPHENYLMETHYLSILANOL | authKW | 42946 | 0% | 100% | 1 |
9 | BIS4 FLUOROPHENYLMETHYLSILYLMETHANOL | authKW | 42946 | 0% | 100% | 1 |
10 | CLITORIA TERNATEA CT FLOWER EXTRACTS | authKW | 42946 | 0% | 100% | 1 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Dermatology | 1991 | 13% | 0% | 93 |
2 | Pharmacology & Pharmacy | 1980 | 32% | 0% | 227 |
3 | Mycology | 1179 | 5% | 0% | 38 |
4 | Medicine, General & Internal | 504 | 14% | 0% | 97 |
5 | Endocrinology & Metabolism | 498 | 11% | 0% | 80 |
6 | Toxicology | 347 | 7% | 0% | 52 |
7 | Microbiology | 222 | 9% | 0% | 62 |
8 | Infectious Diseases | 54 | 3% | 0% | 24 |
9 | Urology & Nephrology | 45 | 3% | 0% | 22 |
10 | Chemistry, Medicinal | 17 | 2% | 0% | 16 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | 840 SHERBROOK ST | 42946 | 0% | 100% | 1 |
2 | DEV ENDOCRINOL UNITHOSP CLIN | 42946 | 0% | 100% | 1 |
3 | EVOLUT EXPTL BIOL | 42946 | 0% | 100% | 1 |
4 | HLTH SCI INTERNAL MED INFECT DIS | 42946 | 0% | 100% | 1 |
5 | HOSP JJ AGUIRRE ANAT PATOL | 42946 | 0% | 100% | 1 |
6 | HOSP JJ AGUIRRE CIRUGIA | 42946 | 0% | 100% | 1 |
7 | MASTER SCI BIOMED SCI PROGRAM | 42946 | 0% | 100% | 1 |
8 | DRUG CONSULTAT CLIN PHARMACOL TOXICOL UNIT | 21472 | 0% | 50% | 1 |
9 | HEPATOBILLIARY ENTER SURG | 21472 | 0% | 50% | 1 |
10 | PROGRAM PHARMACOL DRUG DEV | 21472 | 0% | 50% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MYKOSEN | 35097 | 3% | 4% | 21 |
2 | REVIEWS OF INFECTIOUS DISEASES | 4868 | 2% | 1% | 17 |
3 | VESTNIK DERMATOLOGII I VENEROLOGII | 4611 | 2% | 1% | 17 |
4 | MYCOSES | 2051 | 2% | 0% | 12 |
5 | ACTA ENDOCRINOLOGICA | 1836 | 2% | 0% | 13 |
6 | DRUG METABOLISM AND DISPOSITION | 1628 | 2% | 0% | 17 |
7 | XENOBIOTICA | 1578 | 2% | 0% | 12 |
8 | JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1518 | 3% | 0% | 18 |
9 | JOURNAL OF BIOCHEMICAL TOXICOLOGY | 1498 | 0% | 1% | 3 |
10 | DICP-THE ANNALS OF PHARMACOTHERAPY | 1355 | 1% | 1% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SONINO, N , (1987) DRUG-THERAPY - THE USE OF KETOCONAZOLE AS AN INHIBITOR OF STEROID-PRODUCTION.NEW ENGLAND JOURNAL OF MEDICINE. VOL. 317. ISSUE 13. P. 812-818 | 59 | 87% | 260 |
2 | MIOSSEC, P , ARCHAMBEAUD-MOUVEROUX, F , TEISSIER, MP , (1997) INHIBITION OF STEROIDOGENESIS BY KETOCONAZOLE - THERAPEUTIC USES.ANNALES D ENDOCRINOLOGIE. VOL. 58. ISSUE 6. P. 494-502 | 64 | 67% | 10 |
3 | RODRIGUEZ, RJ , BUCKHOLZ, CJ , (2003) HEPATOTOXICITY OF KETOCONAZOLE IN SPRAGUE-DAWLEY RATS: GLUTATHIONE DEPLETION, FLAVINCONTAINING MONOOXYGENASES-MEDIATED BIOACTIVATION AND HEPATIC COVALENT BINDING.XENOBIOTICA. VOL. 33. ISSUE 4. P. 429-441 | 27 | 82% | 25 |
4 | SONINO, N , (1986) THE ENDOCRINE EFFECTS OF KETOCONAZOLE.JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION. VOL. 9. ISSUE 4. P. 341-347 | 43 | 93% | 16 |
5 | GUPTA, AK , DAIGLE, D , FOLEY, KA , (2015) DRUG SAFETY ASSESSMENT OF ORAL FORMULATIONS OF KETOCONAZOLE.EXPERT OPINION ON DRUG SAFETY. VOL. 14. ISSUE 2. P. 325 -334 | 22 | 49% | 7 |
6 | MAHLER, C , VERHELST, J , DENIS, L , (1993) KETOCONAZOLE AND LIAROZOLE IN THE TREATMENT OF ADVANCED PROSTATIC-CANCER.CANCER. VOL. 71. ISSUE 3. P. 1068-1073 | 24 | 86% | 68 |
7 | BOK, AB , SMALL, EJ , (1999) THE TREATMENT OF ADVANCED PROSTATE CANCER WITH KETOCONAZOLE - SAFETY ISSUES.DRUG SAFETY. VOL. 20. ISSUE 5. P. 451-458 | 23 | 74% | 11 |
8 | DANESHMEND, TK , WARNOCK, DW , (1988) CLINICAL PHARMACOKINETICS OF KETOCONAZOLE.CLINICAL PHARMACOKINETICS. VOL. 14. ISSUE 1. P. 13-34 | 42 | 52% | 146 |
9 | DEPEDRINI, P , TOMMASELLI, A , SPANO, G , MONTEMURRO, G , (1988) CLINICAL AND HORMONAL EFFECTS OF KETOCONAZOLE ON HIRSUTISM IN WOMEN.INTERNATIONAL JOURNAL OF TISSUE REACTIONS-EXPERIMENTAL AND CLINICAL ASPECTS. VOL. 10. ISSUE 3. P. 193-198 | 29 | 94% | 1 |
10 | RODRIGUEZ, RJ , ACOSTA, D , (1995) COMPARISON OF KETOCONAZOLE-INDUCED AND FLUCONAZOLE-INDUCED HEPATOTOXICITY IN A PRIMARY CULTURE SYSTEM OF RAT HEPATOCYTES.TOXICOLOGY. VOL. 96. ISSUE 2. P. 83-92 | 22 | 76% | 33 |
Classes with closest relation at Level 1 |